Copyright © Inderes 2011 - present. All rights reserved.

Hamlet BioPharma

5.12 SEK

+4.07 %

Less than 1K followers

HAMLET B

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+4.07 %
+8.94 %
-14.81 %
+25.95 %
+36.90 %
+59.50 %
+47.00 %
-28.95 %
+131.42 %

Hamlet BioPharma operates in the pharmaceutical industry. The company conducts drug development based on a tumor-killing protein-lipid complex, formed from two natural and harmless molecules found in breast milk. The development aims to produce preparations that will primarily be used for the treatment and prevention of cancer diseases. Hamlet BioPharma was founded in 2015 and is headquartered in Lund.

Read more
Market cap
945.47M SEK
Turnover
120.7K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13/2
2026

Interim report Q2'26

22/5
2026

Interim report Q3'26

28/8
2026

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.